New
With Momentum

DeLorean Artificial Intelligence

The AI engine Fit Assessment

Beta

The company will be attending ViVE 2025 Event

Blurb

DeLorean AI is an artificial intelligence product company with products in healthcare (Medical AI) & sales (Sales AI).

HQ Location

Palm Beach (United States)

Founded

2019

Employees

11 - 50

Total funding raised

$10.50M

Last Funding Event

Series A, $7.50M, August 1, 2023

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M

DeLorean AI is an artificial intelligence product company with products in healthcare (Medical AI) & sales (Sales AI). Medical AI predicts disease onset, transition and next best action (NBA) to slow the progress of disease and get the patient better. Medical AI is the first AI in the world to be biologically validated as well as the first AI to be applied at scale to focus on patient health. Currently, Medical AI has processed 45M patients and touches ~50% of the renal patients in the USA. Medical AI on average saves $100PMPM. Sales AI has been developed for B2B and B2C and is deployed at Fortune 500 companies. Our business model is AI as a Service.